Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-13-011751
Filing Date
2013-07-12
Accepted
2013-07-12 17:09:15
Documents
1
Effectiveness Date
2013-07-12

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-13-011751.paper CERTNAS 294
  Scanned paper document scanned.pdf   40994
  Complete submission text file 9999999997-13-011751.txt   1318
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: CERTNAS | Act: 34 | File No.: 001-36000 | Film No.: 13002605
SIC: 2834 Pharmaceutical Preparations